Your browser doesn't support javascript.
loading
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.
Park, Han-Sol; Shapiro, Janna R; Sitaras, Ioannis; Woldemeskel, Bezawit A; Garliss, Caroline C; Dziedzic, Amanda; Sachithanandham, Jaiprasath; Jedlicka, Anne E; Caputo, Christopher A; Rousseau, Kimberly E; Thakar, Manjusha; Suwanmanee, San; Hauk, Pricila; Aliyu, Lateef; Majewska, Natalia I; Koley, Sushmita; Patel, Bela; Broderick, Patrick; Mosnaim, Giselle; Heath, Sonya L; Spivak, Emily S; Shenoy, Aarthi; Bloch, Evan M; Gniadek, Thomas J; Shoham, Shmuel; Casadevall, Arturo; Hanley, Daniel; Cox, Andrea L; Laeyendecker, Oliver; Betenbaugh, Michael J; Cramer, Steven M; Mostafa, Heba H; Pekosz, Andrew; Blankson, Joel N; Klein, Sabra L; Tobian, Aaron Ar; Sullivan, David; Gebo, Kelly A.
Afiliação
  • Park HS; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Shapiro JR; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Sitaras I; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Woldemeskel BA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Garliss CC; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Dziedzic A; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Sachithanandham J; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Jedlicka AE; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Caputo CA; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Rousseau KE; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Thakar M; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Suwanmanee S; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Hauk P; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
  • Aliyu L; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
  • Majewska NI; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
  • Koley S; Department of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.
  • Patel B; Critical Care Medicine, University of Texas Health, Houston, Texas, USA.
  • Broderick P; Emergency Medicine, Danbury Connecticut, USA.
  • Mosnaim G; Division of Allergy and Immunology, Department of Medicine, Northshore University Health System, Evanston, Illinois, USA.
  • Heath SL; Department of Medicine, Division of Infectious Diseases, University of Alabama Birmingham, Alabama, USA.
  • Spivak ES; Department of Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA.
  • Shenoy A; Hematology Oncology, Medstar Washington Hospital Center, Washington, DC, USA.
  • Bloch EM; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Gniadek TJ; Department of Pathology and Laboratory Medicine, Northshore University Health System, Evanston, Illinois, USA.
  • Shoham S; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Casadevall A; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Hanley D; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Cox AL; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Laeyendecker O; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Betenbaugh MJ; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Cramer SM; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
  • Mostafa HH; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
  • Pekosz A; Department of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.
  • Blankson JN; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Klein SL; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
  • Tobian AA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Sullivan D; Department of Medicine, Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Gebo KA; W. Harry Feinstone Department of Molecular Microbiology and Immunology and.
JCI Insight ; 7(5)2022 03 08.
Article em En | MEDLINE | ID: mdl-35104245

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Sintéticas / Vacinação / Imunidade Adaptativa / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Vacinas de mRNA / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Sintéticas / Vacinação / Imunidade Adaptativa / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Vacinas de mRNA / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article